Analyst Ratings for Edgewise Therapeutics (EWTX)
EWTX Rating Summary
EWTX Price Target Summary
- Highest: $66.00 (Raymond James)
- Lowest: $25.00 (Stifel)
- Average: $48.42
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$48.42 (+21.8%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
Avg. $ Target:
$48.42 (+21.8%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/9/2026 | Oppenheimer | Mazahir Alimohamed | New Coverage | Outperform (N/A) |
51.00 (N/A) |
46.30 (39.76) |
-14.13% | Details |
| 9/25/2025 | Goldman Sachs » Updated 6/17/2026 |
Paul Choi | New Coverage | Neutral (N/A) |
32.00 (N/A) |
15.09 (39.76) |
163.49% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
